November 13 from 12:30 am – 1:15 pm EST
Please join rheumatologist DeAnna Baker Frost, MD, and pulmonologist Steven Nathan, MD, as they engage in a candid discussion about the challenges in the diagnostic process and non-pharmacological management of patients with interstitial lung diseases (ILDs), with a special focus on autoimmune-associated ILDs. Faculty will also discuss the updated 2022 ATS/ERS/JRS/ALAT guideline. This program will focus on the intersection of rheumatology and pulmonology during the diagnostic journey and co-management of patients with ILDs.
This program is developed and offered by Boehringer Ingelheim Pharmaceuticals, Inc. This is not an official program of the American College of Rheumatology.
This is a non-CME event and does not qualify for CME or CE credit. Onsite registration/admission will occur for conference registrants on a first-come, first-serve basis.
Presentation content has been reviewed for consistency with FDA guidelines and is not approved for continuing education credit. Speakers receive fair market value compensation for this presentation. Aspects of this program may be reportable under the Physicians Payment Sunshine Act. Pursuant to the PhRMA (Pharmaceutical Research and Manufacturers of America) Code on Interactions with Healthcare Professionals, attendance at this promotional program is limited to healthcare professionals, attendance by healthcare professionals’ spouses or guests is not permitted.
Steven Nathan MD, FCCP
Inova Fairfax Hospital
Advanced Lung Disease, Lung Transplant, & Inova Lung Services
Falls Church, Virginia
DeAnna Baker Frost MD, PhD
Medical University of South Carolina
Rheumatology and Immunology
Summerville, South Carolina